Global Bone Marrow Transplant Market 2017-2021

  • ID: 4328329
  • Report
  • Region: Global
  • 78 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AllCells
  • BioTime
  • Cesca Therapeutics
  • CORESTEM
  • Hemostemix
  • Merck
  • MORE
About Bone Marrow Transplant

Bone marrow transplant is the medical procedure that is performed to replace the damaged or destroyed bone marrow due to infections, disease, or adverse effect of treatment. A normal bone marrow transplant includes transplantation of blood stem cell that travels to the bone marrow to produce new blood cell and thus improves growth of new marrow. When the bone marrow is damaged due to disease, allogeneic transplant is used whereas autologous transplant is used when bone marrow is intact at the start of disease but it gets damaged due to therapy.

The analysts forecast the global bone marrow transplant market to grow at a CAGR of 5.39% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global bone marrow transplant market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Bone Marrow Transplant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AllCells
  • Lonza
  • Merck
  • Sanofi
Other prominent vendors
  • Athersys
  • Beike Biotechnology
  • BioTime
  • bluebird bio
  • Caladrius
  • Cellular Biomedicine Group
  • Cellular Dynamics International (a subsidiary of Fujifilm)
  • Cesca Therapeutics
  • CHA Biotech
  • Chugai Pharmaceutical
  • CORESTEM
  • Gamida Cell
  • Global Stem Cells Group
  • Hemostemix
  • Histocell
  • Mesoblast
  • TiGenix
  • Translational Biosciences (a subsidiary of Medistem Panama)
Market drivers
  • Technological advancement
  • For a full, detailed list, view the full report
Market challenges
  • Scarcity of donors and its genetical acceptance
  • For a full, detailed list, view the full report
Market trends
  • Growing number of registry
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AllCells
  • BioTime
  • Cesca Therapeutics
  • CORESTEM
  • Hemostemix
  • Merck
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Market landscape
  • Market overview
  • Five forces analysis
PART 06: Market segmentation by transplant type
  • Autologous bone marrow transplant
  • Allogeneic bone marrow transplant
PART 07: Market segmentation by indication
  • Multiple myeloma
  • Acute leukemia
  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Solid tumors
  • Others
PART 08: Geographical segmentation
  • Bone marrow transplant market in EMEA
  • Bone marrow transplant market in Americas
  • Bone marrow transplant market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends
  • Newer application of bone marrow transplant
  • Growing number of registry
  • Online services
PART 12: Vendor landscape
  • Competitive scenario
PART 13: Key vendor analysis
  • AllCells
  • Lonza
  • Merck
  • Sanofi
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Various blood components formed by bone marrow
Exhibit 02: Five phases of transplant process
Exhibit 03: Major reasons for bone marrow damage
Exhibit 04: Complications associated with bone marrow transplant
Exhibit 05: Global bone marrow transplant market snapshot
Exhibit 06: Global bone marrow transplant market 2016-2021 ($ millions)
Exhibit 07: Opportunity analysis in global bone marrow transplant market
Exhibit 08: Five forces analysis
Exhibit 09: Market segmentation by application 2016
Exhibit 10: Global autologous bone marrow transplant market 2016-2021 ($ millions)
Exhibit 11: Global allogeneic bone marrow transplantation market 2016-2021 ($ millions)
Exhibit 12: Bone marrow transplant in various disease conditions 2016
Exhibit 13: Average share of transplant types in multiple myeloma treatment 2010-2014
Exhibit 14: Average share of transplant types in acute leukemia treatment 2010-2014
Exhibit 15: Average share of transplant types in Hodgkin lymphoma treatment 2010-2014
Exhibit 16: Average share of transplant types in non-Hodgkin lymphoma treatment 2010-2014
Exhibit 17: Average share of transplant types in solid tumors treatment 2010-2014
Exhibit 18: Bone marrow transplantation in various other diseases
Exhibit 19: Segmentation of global bone marrow transplant market by geography 2016 and 2021
Exhibit 20: Segmentation of global bone marrow transplant market revenue by geography 2016-2021 ($ millions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Bone marrow transplant market in EMEA 2016-2021 ($ millions)
Exhibit 23: Market scenario in Americas
Exhibit 24: Bone marrow transplant market in Americas 2016-2021 ($ millions)
Exhibit 25: Market Scenario in APAC
Exhibit 26: Bone marrow transplant market in APAC 2016-2021 ($ millions)
Exhibit 27: Various major types of cancers managed by bone marrow transplant
Exhibit 28: NIH: YoY and growth rate of spending toward stem cell research ($ billions)
Exhibit 29: Various phases of bone marrow transplant treatment
Exhibit 30: The supply gap of donors for fulfilling demand of bone marrow
Exhibit 31: Three ethical requirements for bone marrow transplant
Exhibit 32: Various consideration for ethically bound transplant process
Exhibit 33: Newer applications of bone marrow transplant
Exhibit 34: Number of registry across 52 major countries
Exhibit 35: Number of online matches under various programs
Exhibit 36: Competitive structure analysis of global bone marrow transplant market 2016
Exhibit 37: Market penetration of various vendors 2016
Exhibit 38: Strategic success factors of companies in global bone marrow transplant market
Exhibit 39: AllCells: Key highlights
Exhibit 40: AllCells: Strength assessment
Exhibit 41: AllCells: Strategy assessment
Exhibit 42: AllCells: Opportunity assessment
Exhibit 43: Lonza: Key highlights
Exhibit 44: Lonza: Strength assessment
Exhibit 45: Lonza: Strategy assessment
Exhibit 46: Lonza: Opportunity assessment
Exhibit 47: Merck: Key highlights
Exhibit 48: Merck: Strength assessment
Exhibit 49: Merck: Strategy assessment
Exhibit 50: Merck: Opportunity assessment
Exhibit 51: Sanofi: Key highlights
Exhibit 52: Sanofi: Strength assessment
Exhibit 53: Sanofi: Strategy assessment
Exhibit 54: Sanofi: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • AllCells
  • BioTime
  • Cesca Therapeutics
  • CORESTEM
  • Hemostemix
  • Merck
  • MORE
New Report Released: - Global Bone Marrow Transplant Market 2017-2021

The author of the report recognizes the following companies as the key players in the global bone marrow transplant market: AllCells, Lonza, Merck, and Sanofi.

Other Prominent Vendors in the market are: Athersys, Beike Biotechnology, BioTime, bluebird bio, Caladrius, Cellular Biomedicine Group, Cellular Dynamics International (a subsidiary of Fujifilm), Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, CORESTEM, Gamida Cell, Global Stem Cells Group, Hemostemix, Histocell, Mesoblast, TiGenix, and Translational Biosciences (a subsidiary of Medistem Panama).

Commenting on the report, an analyst from the research team said: “One trend in the market is growing number of registry. The number of the donor registry is increasing in recent times globally. Thus, the challenge of scarcity of donor can be fulfilled for future. The European Group for Blood and Marrow Transplant has started an initiative named Bone Marrow Donors Worldwide (BMDW) in which around 52 major countries across the globe have participated.”

According to the report, one driver in the market is technological advancement. The first transplant of bone marrow was carried out in 1956, and since then there have been tremendous improvements as far as technology is concerned. The advancement in technology has led to the more safer procedure and higher success rates of bone marrow transplant. This has improved the acceptance of this procedure, and the number of transplants has improved in recent years.

Further, the report states that one challenge in the market is scarcity of donors and its genetical acceptance. The supply and demand for bone marrow transplant are an imbalance, and it is one of the major challenges for this market. The demand of bone marrow transplant is increasing due to growing prevalence of the various chronic diseases such as cancer and blood-related disorders such as anemia. However, on the other side, the supply of bone marrow is poor due to lesser donors compared with the over-increasing demand.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • AllCells
  • Lonza
  • Merck
  • Sanofi
  • Athersys
  • Beike Biotechnology
  • BioTime
  • bluebird bio
  • Caladrius
  • Cellular Biomedicine Group
  • Cellular Dynamics International
  • Cesca Therapeutics
  • CHA Biotech
  • Chugai Pharmaceutical
  • CORESTEM
  • Gamida Cell
  • Global Stem Cells Group
  • Hemostemix
  • Histocell
  • Mesoblast
  • TiGenix
  • Translational Biosciences
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll